Concepedia

Efficacy, safety, and target engagement of dazukibart, an IFNβ specific monoclonal antibody, in adults with dermatomyositis: a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial

David Fiorentino, Aaron R. Mangold, Victoria P. Werth, Lisa Christopher‐Stine, Alisa N. Femia, Myron Chu, Amy Musiek, Jason C. Sluzevich, Lauren V. Graham, Anthony P. Fernandez,

The Lancet · 2025 · 47 citations · 17 references

DOI

Concepts

References

17

Measurement of health status

Roman Jaeschke, Joel Singer, Gordon Guyatt · Controlled Clinical Trials · 1989 · 4.9K citations

, , +10

2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups

Ingrid E. Lundberg, Anna Tjärnlund, Matteo Bottai et al. · Annals of the Rheumatic Diseases · 2017 · 1.5K citations · Full text

, , +13

Interferon‐α/β–mediated innate immune mechanisms in dermatomyositis

Steven A. Greenberg, Jack L. Pinkus, Geraldine S. Pinkus et al. · Annals of Neurology · 2005 · 612 citations

, , +17

Type I interferon–inducible gene expression in blood is present and reflects disease activity in dermatomyositis and polymyositis

Ronan J. Walsh, Sek Won Kong, Yihong Yao et al. · Arthritis & Rheumatism · 2007 · 304 citations · Full text

, , +17

The EuroMyositis registry: an international collaborative tool to facilitate myositis research

James B Lilleker, Jiří Vencovský, Guochun Wang et al. · Annals of the Rheumatic Diseases · 2017 · 275 citations · Full text

, , +9